These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 30391574)
1. Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings. Imai R; Ono M; Nishimura N; Suzuki K; Komiyama N; Tamura T J Thorac Oncol; 2019 Feb; 14(2):e36-e38. PubMed ID: 30391574 [No Abstract] [Full Text] [Related]
2. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma. Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673 [TBL] [Abstract][Full Text] [Related]
3. Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade. Tomoaia R; Beyer RȘ; Pop D; Minciună IA; Dădârlat-Pop A Eur J Cancer; 2020 Jun; 132():224-227. PubMed ID: 32336614 [No Abstract] [Full Text] [Related]
4. Atezolizumab-induced myositis and myocarditis in a patient with metastatic urothelial carcinoma. Sessums M; Yarrarapu S; Guru PK; Sanghavi DK BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33298477 [TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab and epacadostat induced fatal myocarditis and myositis presenting as a case of ptosis and ophthalmoplegia. Hellman JB; Traynis I; Lin LK Orbit; 2019 Jun; 38(3):244-247. PubMed ID: 29985683 [TBL] [Abstract][Full Text] [Related]
7. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring. Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257 [TBL] [Abstract][Full Text] [Related]
8. Severe myocarditis with slight lymphocytic infiltration after nivolumab treatment. Edahiro R; Shiroyama T; Hijiki S; Nojima S; Shirai Y; Koyama S; Kumanogoh A Lung Cancer; 2020 Feb; 140():116-117. PubMed ID: 31848027 [No Abstract] [Full Text] [Related]
9. Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review. Kadota H; Gono T; Shirai Y; Okazaki Y; Takeno M; Kuwana M Curr Rheumatol Rep; 2019 Feb; 21(4):10. PubMed ID: 30790071 [TBL] [Abstract][Full Text] [Related]
10. Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti-programmed death 1 antibody. Shirai T; Kiniwa Y; Sato R; Sano T; Nakamura K; Mikoshiba Y; Ohashi N; Sekijima Y; Okuyama R Eur J Cancer; 2019 Jan; 106():193-195. PubMed ID: 30528803 [No Abstract] [Full Text] [Related]
11. Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis. Salem JE; Allenbach Y; Vozy A; Brechot N; Johnson DB; Moslehi JJ; Kerneis M N Engl J Med; 2019 Jun; 380(24):2377-2379. PubMed ID: 31189043 [No Abstract] [Full Text] [Related]
13. Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely. Spallarossa P; Tini G; Sarocchi M; Arboscello E; Grossi F; Queirolo P; Zoppoli G; Ameri P J Clin Oncol; 2019 Sep; 37(25):2201-2205. PubMed ID: 31084547 [No Abstract] [Full Text] [Related]
14. Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma. Vallet H; Gaillet A; Weiss N; Vanhaecke C; Saheb S; Touitou V; Franck N; Kramkimel N; Borden A; Touat M; Ricard D; Verny M; Maisonobe T; Psimaras D Ann Oncol; 2016 Jul; 27(7):1352-3. PubMed ID: 26940685 [No Abstract] [Full Text] [Related]
15. Immunotherapy- A double Edged Sword; A case of Fatal Myocarditis and Complete Response. Peters N; Greally M; Breen K; Fabre A; Blazkova S Ir Med J; 2019 May; 112(5):937. PubMed ID: 31411390 [No Abstract] [Full Text] [Related]
16. Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms. Champion SN; Stone JR Mod Pathol; 2020 Jan; 33(1):99-108. PubMed ID: 31534205 [TBL] [Abstract][Full Text] [Related]
17. Nivolumab-associated myositis myocarditis and myasthenia and anti-striated muscle antibodies. Fazal M; Prentice DA; Kho LK; Fysh E Intern Med J; 2020 Aug; 50(8):1003-1006. PubMed ID: 33306231 [TBL] [Abstract][Full Text] [Related]
18. Tracheoesophageal Fistula Caused by Successful Response to Pembrolizumab in a Patient With Squamous Cell Lung Cancer. Wang H; Zhang L; Liu W J Thorac Oncol; 2019 Jul; 14(7):e141-e143. PubMed ID: 31235036 [No Abstract] [Full Text] [Related]
19. Immune checkpoint inhibitor-related myositis and myocarditis with multiple myositis-specific/-associated antibodies. Isa M; Hongo Y; Sakamoto N; Yamazaki K; Takazaki H; Asakuma J; Ikewaki K; Suzuki K J Neurol Sci; 2023 Jan; 444():120528. PubMed ID: 36565689 [No Abstract] [Full Text] [Related]
20. New drugs and new toxicities: pembrolizumab-induced myocarditis. Inayat F; Masab M; Gupta S; Ullah W BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29367376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]